Sagent Pharmaceuticals News and Activities

Sagent Pharmaceuticals is a company listed under the stock ticker SGNT (US).

View the org chart displaying its 19 main executives

Most searched biographies at Sagent Pharmaceuticals

• Vishy Chebrol, Chief Executive Officer
• Jyothi Chaluvadi, Vice President of Business Development & Growth ...
• Don Bullock, Executive Vice President, Commercial Operations

Popular executive movements at Sagent Pharmaceuticals

• Jyothi Chaluvadi, who was Senior Director, Business Development and Growth Strategy, is promoted to Vice President of Business Development & Growth Strategy  (posted on January 12 2026).

Create your alert
to follow the executive moves at Sagent Pharmaceuticals.

Sagent Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Sagent Pharmaceuticals

Social media about Sagent Pharmaceuticals

• Sagent Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Sagent Pharmaceuticals on LinkedIn, X (Twitter) & YouTube